Mechanisms and Treatment of Chronic Allograft Injury (CAI) Due to Calcineurin Inhibitor (CNI) Toxicity
Status:
Terminated
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out how well the current drug regimen (including low
Prograf dose and Myfortic, which is usually recommended to prevent any further deterioration
in the kidney function) works and how safe it is when compared to a combination of Zortress
and Myfortic in patients with chronic kidney injury associated with Prograf or Neoral use.